⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iib pancreatic cancer

Every month we try and update this database with for stage iib pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersNCT01846520
Healthy Subject
Localized Trans...
Metastatic Tran...
Psychosocial Ef...
Recurrent Bladd...
Recurrent Cervi...
Recurrent Colon...
Recurrent Gastr...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Renal...
Recurrent Trans...
Recurrent Ureth...
Recurrent Uteri...
Regional Transi...
Stage II Bladde...
Stage II Renal ...
Stage II Urethr...
Stage IIA Cervi...
Stage IIA Colon...
Stage IIA Gastr...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIA Pancr...
Stage IIA Recta...
Stage IIA Uteri...
Stage IIB Cervi...
Stage IIB Colon...
Stage IIB Gastr...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIB Pancr...
Stage IIB Recta...
Stage IIB Uteri...
Stage IIC Colon...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIC Recta...
Stage III Bladd...
Stage III Pancr...
Stage III Renal...
Stage III Ureth...
Stage IIIA Cerv...
Stage IIIA Colo...
Stage IIIA Gast...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Rect...
Stage IIIA Uter...
Stage IIIB Cerv...
Stage IIIB Colo...
Stage IIIB Gast...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Rect...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Rect...
Stage IIIC Uter...
Stage IV Bladde...
Stage IV Gastri...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Renal ...
Stage IV Urethr...
Stage IVA Cervi...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Uteri...
Stage IVB Cervi...
Stage IVB Colon...
Stage IVB Recta...
Stage IVB Uteri...
Ureter Cancer
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
educational int...
telephone-based...
quality-of-life...
questionnaire a...
18 Years - City of Hope Medical Center
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II StudyNCT02345460
Pancreatic Aden...
Poorly Differen...
Resectable Panc...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
Undifferentiate...
Irinotecan Hydr...
Oxaliplatin
Leucovorin Calc...
Fluorouracil
Laboratory Biom...
18 Years - 75 YearsCase Comprehensive Cancer Center
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By SurgeryNCT00305877
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
cetuximab
gemcitabine hyd...
capecitabine
radiation thera...
bevacizumab
laboratory biom...
18 Years - National Cancer Institute (NCI)
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerNCT01959672
Pancreatic Aden...
Resectable Panc...
Stage I Pancrea...
Stage IA Pancre...
Stage IB Pancre...
Stage II Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
4-Dimensional C...
Fluorouracil
Gemcitabine Hyd...
Laboratory Biom...
Leucovorin Calc...
Nelfinavir Mesy...
Oregovomab
Stereotactic Bo...
Therapeutic Con...
19 Years - University of Nebraska
Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based ChemotherapyNCT02414100
Pancreatic Duct...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
Stage IV Pancre...
Laboratory Biom...
Cytology Specim...
18 Years - Thomas Jefferson University
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With SurgeryNCT01234935
Acinar Cell Ade...
Duct Cell Adeno...
Recurrent Pancr...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
dasatinib
gemcitabine hyd...
laboratory biom...
mutation analys...
nucleic acid se...
immunohistochem...
18 Years - Translational Oncology Research International
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic CancerNCT02349867
Pancreatic Aden...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
Recurrent Pancr...
Gemcitabine
Sorafenib
Vorinostat
3-Dimensional C...
Intensity-Modul...
RosetteSep
DEPfff
18 Years - Virginia Commonwealth University
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic CancerNCT01918644
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
stereotactic bo...
capecitabine
therapeutic con...
magnetic resona...
laboratory biom...
19 Years - University of Wisconsin, Madison
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic CancerNCT03825289
Metastatic Panc...
Stage II Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
Stage IV Pancre...
Unresectable Pa...
Hydroxychloroqu...
Trametinib
18 Years - University of Utah
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With SurgeryNCT01234935
Acinar Cell Ade...
Duct Cell Adeno...
Recurrent Pancr...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
dasatinib
gemcitabine hyd...
laboratory biom...
mutation analys...
nucleic acid se...
immunohistochem...
18 Years - Translational Oncology Research International
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerNCT01959672
Pancreatic Aden...
Resectable Panc...
Stage I Pancrea...
Stage IA Pancre...
Stage IB Pancre...
Stage II Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
4-Dimensional C...
Fluorouracil
Gemcitabine Hyd...
Laboratory Biom...
Leucovorin Calc...
Nelfinavir Mesy...
Oregovomab
Stereotactic Bo...
Therapeutic Con...
19 Years - University of Nebraska
Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic CancerNCT02307539
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
Stage IV Pancre...
Psychosocial As...
Palliative Ther...
Quality-of-Life...
Questionnaire A...
21 Years - City of Hope Medical Center
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic CancerNCT03825289
Metastatic Panc...
Stage II Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
Stage IV Pancre...
Unresectable Pa...
Hydroxychloroqu...
Trametinib
18 Years - University of Utah
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerNCT01959672
Pancreatic Aden...
Resectable Panc...
Stage I Pancrea...
Stage IA Pancre...
Stage IB Pancre...
Stage II Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
4-Dimensional C...
Fluorouracil
Gemcitabine Hyd...
Laboratory Biom...
Leucovorin Calc...
Nelfinavir Mesy...
Oregovomab
Stereotactic Bo...
Therapeutic Con...
19 Years - University of Nebraska
Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the PancreasNCT01298401
Pancreatic Canc...
ganitumab
capecitabine
gemcitabine hyd...
3-dimensional c...
18 Years - Radiation Therapy Oncology Group
Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the PancreasNCT01298401
Pancreatic Canc...
ganitumab
capecitabine
gemcitabine hyd...
3-dimensional c...
18 Years - Radiation Therapy Oncology Group
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic CancerNCT01918644
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
stereotactic bo...
capecitabine
therapeutic con...
magnetic resona...
laboratory biom...
19 Years - University of Wisconsin, Madison
Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303NCT01664169
Pancreatic Canc...
laboratory biom...
18 Years - Alliance for Clinical Trials in Oncology
Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by SurgeryNCT01739439
Acinar Cell Ade...
Duct Cell Adeno...
Stage IIB Pancr...
Stage III Pancr...
gemcitabine hyd...
hyperfractionat...
intensity-modul...
radiosurgery
diffusion-weigh...
18 Years - Fox Chase Cancer Center
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryNCT00482625
Intraductal Pap...
Recurrent Pancr...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
erlotinib hydro...
conventional su...
immunohistochem...
protein express...
biopsy
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With SurgeryNCT01234935
Acinar Cell Ade...
Duct Cell Adeno...
Recurrent Pancr...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
dasatinib
gemcitabine hyd...
laboratory biom...
mutation analys...
nucleic acid se...
immunohistochem...
18 Years - Translational Oncology Research International
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryNCT02511821
Stage I Adult L...
Stage I Colorec...
Stage IA Gastri...
Stage IA Pancre...
Stage IB Gastri...
Stage IB Pancre...
Stage II Adult ...
Stage IIA Color...
Stage IIA Gastr...
Stage IIA Pancr...
Stage IIB Color...
Stage IIB Gastr...
Stage IIB Pancr...
Stage IIC Color...
Stage III Pancr...
Stage IIIA Adul...
Stage IIIA Colo...
Stage IIIA Gast...
Stage IIIB Adul...
Stage IIIB Colo...
Stage IIIB Gast...
Stage IIIC Adul...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IV Gastri...
Stage IVA Color...
Stage IVA Liver...
Stage IVA Pancr...
Stage IVB Color...
Stage IVB Liver...
Stage IVB Pancr...
Computer-Assist...
Vivofit watch
Quality-of-Life...
Questionnaire A...
21 Years - City of Hope Medical Center
Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by SurgeryNCT01739439
Acinar Cell Ade...
Duct Cell Adeno...
Stage IIB Pancr...
Stage III Pancr...
gemcitabine hyd...
hyperfractionat...
intensity-modul...
radiosurgery
diffusion-weigh...
18 Years - Fox Chase Cancer Center
Perioperative Therapy for Resectable Pancreatic CancerNCT00609336
Adenocarcinoma ...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
gemcitabine hyd...
docetaxel
capecitabine
intensity-modul...
oxaliplatin
pancreatic surg...
therapeutic con...
laboratory biom...
18 Years - University of Washington
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By SurgeryNCT00305877
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
cetuximab
gemcitabine hyd...
capecitabine
radiation thera...
bevacizumab
laboratory biom...
18 Years - National Cancer Institute (NCI)
Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic CancerNCT02307539
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
Stage IV Pancre...
Psychosocial As...
Palliative Ther...
Quality-of-Life...
Questionnaire A...
21 Years - City of Hope Medical Center
Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic CancerNCT02349867
Pancreatic Aden...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
Recurrent Pancr...
Gemcitabine
Sorafenib
Vorinostat
3-Dimensional C...
Intensity-Modul...
RosetteSep
DEPfff
18 Years - Virginia Commonwealth University
Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the PancreasNCT01298401
Pancreatic Canc...
ganitumab
capecitabine
gemcitabine hyd...
3-dimensional c...
18 Years - Radiation Therapy Oncology Group
Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by SurgeryNCT01954732
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
metformin hydro...
pharmacological...
18 Years - Case Comprehensive Cancer Center
Perioperative Therapy for Resectable Pancreatic CancerNCT00609336
Adenocarcinoma ...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
gemcitabine hyd...
docetaxel
capecitabine
intensity-modul...
oxaliplatin
pancreatic surg...
therapeutic con...
laboratory biom...
18 Years - University of Washington
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic CancerNCT02047474
Acinar Cell Ade...
Duct Cell Adeno...
Stage I Pancrea...
Stage IIA Pancr...
Stage IIB Pancr...
oxaliplatin
leucovorin calc...
irinotecan hydr...
fluorouracil
therapeutic con...
laboratory biom...
18 Years - Yale University
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryNCT00482625
Intraductal Pap...
Recurrent Pancr...
Stage IA Pancre...
Stage IB Pancre...
Stage IIA Pancr...
Stage IIB Pancr...
Stage III Pancr...
erlotinib hydro...
conventional su...
immunohistochem...
protein express...
biopsy
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: